To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
KKR and Ampersand make takeover bid for Oxford Immunotec: Reuters
KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters.
